Journal of substance abuse treatment

Veterans' primary care experiences with opioid addiction treatment in the Veterans Health Administration

Updated

Abstract

Patients with opioid use disorder (OUD) reported 31% positive experiences with access to care.

  • Patients with OUD experienced the least positive feedback on access and medication decision-making, at 31% and 35%, respectively.
  • They also reported the highest negative experiences in self-management support (35%) and provider communication (23%).
  • Compared to patients with other substance use disorders (SUDs) and no SUD, OUD patients indicated fewer positive and more negative experiences across various care aspects.
  • Among those treated with buprenorphine, there were more positive experiences reported in care comprehensiveness (aRD = 8.3) and self-management support (aRD = 7.1).
  • Buprenorphine treatment was also linked to fewer negative experiences in care coordination (aRD = -4.9) and medication shared decision-making (aRD = -5.4).

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declaration of competing interest Dr. Stefan G. Kertesz asserts past ownership of stock in Merck and Abbot in his personal portfolio, never amounting to >3% of assets, and sold in December of 2017. He reports no other history of grants, contracts, honoraria, or any other form of income or assets related to the pharmaceutical industry. No other potential conflicts of interest were identified.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free